These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 17460037)

  • 1. The generation of influenza outbreaks by a network of host immune responses against a limited set of antigenic types.
    Recker M; Pybus OG; Nee S; Gupta S
    Proc Natl Acad Sci U S A; 2007 May; 104(18):7711-6. PubMed ID: 17460037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influenza vaccine--outmaneuvering antigenic shift and drift.
    Treanor J
    N Engl J Med; 2004 Jan; 350(3):218-20. PubMed ID: 14724300
    [No Abstract]   [Full Text] [Related]  

  • 3. Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control.
    Hilleman MR
    Vaccine; 2002 Aug; 20(25-26):3068-87. PubMed ID: 12163258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sera from Individuals with Narrowly Focused Influenza Virus Antibodies Rapidly Select Viral Escape Mutations
    Davis AKF; McCormick K; Gumina ME; Petrie JG; Martin ET; Xue KS; Bloom JD; Monto AS; Bushman FD; Hensley SE
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30045982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic evolution of viruses in host populations.
    Rouzine IM; Rozhnova G
    PLoS Pathog; 2018 Sep; 14(9):e1007291. PubMed ID: 30208108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cross-immunization model for the extinction of old influenza strains.
    Uekermann F; Sneppen K
    Sci Rep; 2016 May; 6():25907. PubMed ID: 27174658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Characteristics of epidemiological strains of influenza A virus (H3N2) isolate in 1997-1999. Virus A/Moscow/10/99--a candidate to become the vaccine strain].
    Slepushkin AN; Ivanova VT; Burtseva EI; Oskerko TA; Volodina TN; Kuribko SG; Kolobukhina LV; Beda MV
    Vopr Virusol; 2000; 45(4):22-4. PubMed ID: 10971961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemic dynamics and antigenic evolution in a single season of influenza A.
    Boni MF; Gog JR; Andreasen V; Feldman MW
    Proc Biol Sci; 2006 Jun; 273(1592):1307-16. PubMed ID: 16777717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-circulation of influenza A virus strains and emergence of pandemic via reassortment: the role of cross-immunity.
    Zhang XS; De Angelis D; White PJ; Charlett A; Pebody RG; McCauley J
    Epidemics; 2013 Mar; 5(1):20-33. PubMed ID: 23438428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epochal evolution shapes the phylodynamics of interpandemic influenza A (H3N2) in humans.
    Koelle K; Cobey S; Grenfell B; Pascual M
    Science; 2006 Dec; 314(5807):1898-903. PubMed ID: 17185596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antigenic heterogeneity of human influenza virus type A populations and its role in the epidemic process].
    Beliakov VD; Golubev DB; Zuev VA; Karpukhin GI; Medvedeva MN
    Vestn Akad Med Nauk SSSR; 1983; (5):23-8. PubMed ID: 6191450
    [No Abstract]   [Full Text] [Related]  

  • 12. Viva la revolución: rethinking influenza a virus antigenic drift.
    Yewdell JW
    Curr Opin Virol; 2011 Sep; 1(3):177-83. PubMed ID: 22034587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenic and biochemical heterogeneity of influenza A viruses.
    Oxford JS; Schild GC
    NIPH Ann; 1980 May; 3(1):39-48. PubMed ID: 6161326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epitope specific T-cell responses against influenza A in a healthy population.
    Savic M; Dembinski JL; Kim Y; Tunheim G; Cox RJ; Oftung F; Peters B; Mjaaland S
    Immunology; 2016 Feb; 147(2):165-77. PubMed ID: 26489873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of genomics in tracking the evolution of influenza A virus.
    McHardy AC; Adams B
    PLoS Pathog; 2009 Oct; 5(10):e1000566. PubMed ID: 19855818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of cross-protective vaccines on epidemiological and evolutionary dynamics of influenza.
    Arinaminpathy N; Ratmann O; Koelle K; Epstein SL; Price GE; Viboud C; Miller MA; Grenfell BT
    Proc Natl Acad Sci U S A; 2012 Feb; 109(8):3173-7. PubMed ID: 22323589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparing for the Next Influenza Pandemic: The Development of a Universal Influenza Vaccine.
    Crank MC; Mascola JR; Graham BS
    J Infect Dis; 2019 Apr; 219(Suppl_1):S107-S109. PubMed ID: 30715413
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterizing genetic and antigenic divergence from vaccine strain of influenza A and B viruses circulating in Thailand, 2017-2020.
    Suntronwong N; Klinfueng S; Korkong S; Vichaiwattana P; Thongmee T; Vongpunsawad S; Poovorawan Y
    Sci Rep; 2021 Jan; 11(1):735. PubMed ID: 33437008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genomic and antigenic analysis of strains of influenza A virus (H1N1) isolated in 1982-1983: approaches to the choice of the optimal vaccine strain].
    Akopova II; Klimov AI; Unanov SS; Krasnova VP; Grinbaum EB
    Vopr Virusol; 1986; 31(3):288-92. PubMed ID: 2429448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Epidemiologic aspects of the anthroponotic concept of the origin of pandemic and epidemic strains of influenza A virus].
    Karpukhin GI; Golubev DB
    Zh Mikrobiol Epidemiol Immunobiol; 1983 May; (5):13-8. PubMed ID: 6349184
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.